In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
-
EVENTS - 17-04-2016
Kedrion initiatives for World Hemophilia Day 2016
The goal is to improve access to treatments for people suffering from hemorrhagic conditions
read more -
EVENTS - 07-12-2015
Hemophilia A. SIPPET study selected by the American Society of Hematology
Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies
read more -
EVENTS - 09-11-2015
Kedrion among the key players of Farmindustria's roadshow in Siena
The Lucca-based company presented as one of the innovative pharmaceutical companies in Tuscany
read more -
EVENTS - 13-07-2015
Revolutionary PID testing from Tuscany, Italy
Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 